Residency · Residency · Respirology

Mechanical Ventilation - Modes and Management

Fundamentals of Mechanical Ventilation

Equation of Motion

The equation of motion is the fundamental mathematical relationship governing mechanical ventilation: Paw = (V/C) + (Flow x R) + PEEP_total, where Paw represents airway pressure, V is tidal volume, C is compliance, R is resistance, and PEEP_total includes both applied PEEP and any intrinsic (auto) PEEP. This equation establishes that the pressure required to deliver a breath must overcome both the elastic forces of the respiratory system (represented by V/C) and the resistive forces of the airways and endotracheal tube (represented by Flow x R). The ventilator can independently control only one of two variables at any given time: either pressure or volume (flow). Understanding this equation is not merely an academic exercise; it is essential for troubleshooting ventilator alarms, interpreting waveforms, and optimizing patient-ventilator interaction in clinical practice.

Key Ventilator Parameters

Several fundamental parameters must be set and monitored during mechanical ventilation. Tidal volume is typically targeted at 6 to 8 mL/kg of ideal body weight for most patients, with further reduction to 4 to 6 mL/kg in patients with ARDS. Respiratory rate, usually set between 12 and 20 breaths per minute, is adjusted to achieve the desired minute ventilation and PaCO2. Positive end-expiratory pressure prevents end-expiratory alveolar collapse, with a typical starting value of 5 cmH2O that may be increased substantially in conditions such as ARDS. FiO2 is titrated to a target SpO2, generally 88% to 95%, while minimizing exposure to prevent oxygen toxicity. Inspiratory time and the ratio of inspiration to expiration (I:E ratio) are set according to the clinical scenario: a normal I:E ratio of 1:2 to 1:3 is appropriate for most patients, whereas obstructive lung disease requires prolonged expiratory time with ratios of 1:3 to 1:5 to mitigate air trapping. Flow rate and pattern, either constant (square wave) or decelerating, influence peak airway pressure and the distribution of inspired gas within the lung.

Ventilator Modes

Volume-Controlled Ventilation (VCV)

In volume-controlled ventilation, the ventilator delivers a preset tidal volume at a preset flow rate and pattern. The independent variables under clinician control are tidal volume, respiratory rate, flow rate, PEEP, and FiO2. Because tidal volume is guaranteed, the dependent variable becomes airway pressure, which varies from breath to breath as the patient's compliance and resistance change. The principal advantage of VCV is the guarantee of a predictable tidal volume and thus reliable minute ventilation, which is particularly important in the acute setting where changes in patient effort or lung mechanics might otherwise lead to hypoventilation. The disadvantage is that pressure is uncontrolled and may reach injuriously high levels if compliance decreases (as in progressive ARDS) or resistance increases (as in bronchospasm). Additionally, the fixed flow pattern may not match the patient's inspiratory demand, leading to flow dyssynchrony and patient discomfort.

Pressure-Controlled Ventilation (PCV)

Pressure-controlled ventilation delivers breaths at a preset inspiratory pressure for a defined inspiratory time. The independent variables are inspiratory pressure (Pinsp), inspiratory time, respiratory rate, PEEP, and FiO2. The dependent variable is tidal volume, which varies according to the patient's instantaneous compliance and resistance. PCV generates a decelerating flow pattern that may better match patient inspiratory demand and produces more uniform gas distribution within the lung. Peak airway pressures are inherently limited by the set pressure level, providing a degree of protection against barotrauma. However, the fundamental disadvantage is that tidal volume is not guaranteed; any change in compliance or resistance will alter the delivered volume. This mandates close and continuous monitoring of exhaled tidal volumes, as silent reductions in compliance (worsening edema, atelectasis) can lead to progressive hypoventilation, while improvements in compliance can produce unexpectedly large tidal volumes.

Assist-Control (AC)

Assist-control is a mode in which every breath, whether patient-triggered or time-triggered, is a full machine-delivered breath. Assist-control can operate in either volume-targeted (V-AC) or pressure-targeted (P-AC) configurations. When the patient initiates a breath by generating sufficient inspiratory effort to meet the trigger threshold (either a flow trigger or pressure trigger), the ventilator delivers the full preset breath. If the patient does not trigger within the set time interval, the ventilator delivers a mandatory time-triggered breath, ensuring a minimum respiratory rate. The risk of assist-control is that patients with elevated respiratory drive may trigger excessively, leading to respiratory alkalosis, dynamic hyperinflation, and auto-PEEP, particularly in the setting of obstructive lung disease. Despite these considerations, assist-control remains the most commonly used mode for initial ventilation of critically ill patients because it provides consistent, predictable ventilatory support.

SIMV (Synchronized Intermittent Mandatory Ventilation)

Synchronized intermittent mandatory ventilation delivers a set number of mandatory breaths per minute, which may be volume-controlled or pressure-controlled, synchronized to the patient's inspiratory effort when possible. Between mandatory breaths, the patient breathes spontaneously, either unassisted or with added pressure support. SIMV was originally conceived as a weaning mode, with the rationale that gradually reducing the mandatory rate would train the respiratory muscles for independent breathing. However, clinical experience and evidence have demonstrated that the spontaneous breaths between mandatory breaths impose significant work of breathing, as the patient must overcome the resistance of the ventilator circuit and endotracheal tube without full assistance. Furthermore, trials comparing weaning strategies have shown no benefit of SIMV over pressure support weaning or daily spontaneous breathing trials. Consequently, SIMV has been largely abandoned as a first-choice mode in most contemporary ICUs, though it remains available on modern ventilators.

Pressure Support Ventilation (PSV)

Pressure support ventilation is a patient-triggered, pressure-limited, flow-cycled mode in which the patient retains control over respiratory rate, inspiratory time, and, to some degree, tidal volume. Each breath is initiated by the patient, and the ventilator augments the inspiratory effort by delivering gas at the preset pressure level until the inspiratory flow decays to approximately 25% of peak flow, at which point the ventilator cycles to expiration. This flow-cycling mechanism allows the patient's neural respiratory timing to largely determine breath duration, promoting synchrony and comfort. Pressure support is commonly used for spontaneous breathing trials, with a level of 5 to 8 cmH2O above PEEP of 5 cmH2O representing a commonly employed SBT configuration, though it should be noted that this differs from a T-piece trial in that some ventilatory assistance is still provided. Higher levels of pressure support, typically 5 to 15 cmH2O above PEEP, are used during weaning and as the primary ventilatory mode in less sedated, spontaneously breathing patients.

<image>A comparative diagram showing four common ventilator modes with their waveforms. For each mode (Volume-Controlled AC, Pressure-Controlled AC, SIMV+PS, and PSV), display three synchronized waveform tracings: pressure-time (showing Ppeak, Pplat where applicable, PEEP), flow-time (showing inspiratory and expiratory flow patterns), and volume-time (showing tidal volume). Highlight key differences: VCV has square flow wave and variable pressure; PCV has decelerating flow and constant pressure; SIMV shows mandatory breaths interspersed with spontaneous PS breaths; PSV shows patient-triggered, flow-cycled breaths with variable timing. Label trigger types (flow trigger vs. pressure trigger), cycling criteria (time-cycled vs. flow-cycled), and control variables. Use consistent color coding: mandatory breaths in blue, spontaneous breaths in green.</image>

Advanced Modes

APRV (Airway Pressure Release Ventilation)

Airway pressure release ventilation maintains a sustained high level of continuous positive airway pressure (P-high) with intermittent brief releases to a lower pressure level (P-low), creating what is conceptually an inverse-ratio, pressure-release mode. Typical settings include P-high of 20 to 35 cmH2O, T-high of 4 to 6 seconds, P-low of 0 cmH2O, and T-low of 0.5 to 0.8 seconds. The T-low is typically set to terminate at 75% of peak expiratory flow to maintain end-expiratory lung volume and prevent derecruitment. The fundamental concept is an open-lung approach: the prolonged high pressure maintains continuous alveolar recruitment, while the brief pressure releases provide ventilation. Spontaneous breathing is encouraged and can occur during both the high-pressure and release phases. The evidence base for APRV remains limited, with no randomized controlled trials demonstrating a mortality benefit over conventional lung-protective ventilation. While APRV may improve oxygenation and hemodynamic parameters in selected patients, it carries significant risks including difficulty in reliably measuring tidal volume, potential generation of excessively large tidal volumes, and a requirement for substantial clinician expertise in management.

NAVA (Neurally Adjusted Ventilatory Assist)

Neurally adjusted ventilatory assist represents a fundamentally different approach to ventilatory support by using the electrical activity of the diaphragm (Edi), measured via a specialized esophageal catheter with electrode arrays, to proportionally control the level of ventilatory assistance. The ventilator assist is delivered in direct proportion to the neural respiratory drive, creating a continuously adaptive system that follows the patient's own respiratory center output. This proportional coupling between neural drive and ventilatory support offers several theoretical and practical advantages: it eliminates trigger dyssynchrony because the ventilator responds to neural rather than pneumatic signals, eliminates cycling dyssynchrony because the ventilator follows the neural inspiratory and expiratory timing, and automatically adjusts to changing respiratory demands without clinician intervention. Clinical studies have consistently demonstrated improved patient-ventilator synchrony compared with pressure support ventilation, though no mortality benefit has been established. NAVA finds particular utility in patients with significant dyssynchrony on conventional modes, in difficult weaning scenarios, and in non-invasive ventilation applications.

PAV+ (Proportional Assist Ventilation Plus)

Proportional assist ventilation plus amplifies the patient's own inspiratory effort in proportion to a clinician-set percentage of the total work of breathing. The ventilator estimates the patient's instantaneous compliance and resistance in real-time and adjusts the pressure delivered to achieve the target percentage of assistance. For example, setting 80% assistance means the ventilator provides 80% of the total work of breathing while the patient contributes 20%. PAV+ shares the philosophical approach of NAVA in providing proportional, patient-driven support, but it does not require an esophageal catheter, instead using flow and pressure measurements to estimate respiratory mechanics.

Closed-Loop Modes

Closed-loop ventilation modes represent the growing integration of automation into mechanical ventilation. Adaptive support ventilation (ASV) automatically adjusts tidal volume and respiratory rate to meet a target minute ventilation while minimizing the work of breathing, based on the Otis equation for optimal breathing frequency. IntelliVent-ASV extends this concept by adding automatic adjustment of FiO2 and PEEP based on oxygenation targets and end-tidal CO2 monitoring. While there is growing interest in automation to reduce the cognitive burden on clinicians and potentially reduce the time to liberation from ventilation, limited randomized controlled trial evidence currently exists to demonstrate superiority of these modes over conventional clinician-directed ventilation.

Monitoring and Troubleshooting

Respiratory Mechanics Assessment

Systematic assessment of respiratory mechanics is essential for safe and effective mechanical ventilation. Peak airway pressure (Ppeak) reflects both the resistive and elastic components of the respiratory system and is elevated by bronchospasm, airway secretions, endotracheal tube narrowing, and reduced lung or chest wall compliance. Plateau pressure (Pplat), measured with an end-inspiratory hold maneuver that eliminates the flow-dependent resistive component, reflects purely the elastic recoil of the lung and chest wall and should be maintained at 30 cmH2O or less. Driving pressure (deltaP = Pplat - PEEP) reflects the strain imposed on the functional lung and is targeted at 14 cmH2O or less in ARDS.

Auto-PEEP, also termed intrinsic PEEP, is measured with an end-expiratory hold maneuver and is present when expiratory flow has not reached zero before the next breath is initiated. It occurs in obstructive lung disease, with high minute ventilation, or when expiratory time is insufficient. Auto-PEEP increases the work of triggering, contributes to hemodynamic instability by elevating intrathoracic pressure, and may cause overdistension of already hyperinflated lung units. Static compliance, calculated as tidal volume divided by the difference between plateau pressure and total PEEP, normally ranges from 50 to 80 mL/cmH2O; values are characteristically reduced in ARDS (20-40 mL/cmH2O), pulmonary edema, fibrosis, and chest wall restriction.

High-Pressure Alarm Approach (Elevated Ppeak)

A systematic approach to elevated peak airway pressure begins with differentiating between elevated resistance and reduced compliance. If the plateau pressure is also elevated (elevated Ppeak with elevated Pplat), the problem is one of reduced compliance: the clinician should consider ARDS progression, pulmonary edema, pneumothorax, mainstem bronchus intubation, abdominal distension, or chest wall rigidity (as from burns or neuromuscular blockade wearing off). If the plateau pressure is normal while the peak pressure is elevated (elevated Ppeak with normal Pplat), the problem is one of increased resistance: bronchospasm, airway secretions, a kinked endotracheal tube, or the patient biting the tube should be considered. A practical bedside algorithm involves first checking the endotracheal tube for kinking or malposition, performing suctioning to clear secretions, auscultating the chest for bronchospasm, performing a chest radiograph or point-of-care ultrasound to evaluate for pneumothorax, effusion, or mainstem intubation, and examining the abdomen for distension.

Patient-Ventilator Dyssynchrony

Patient-ventilator dyssynchrony, defined as a mismatch between the patient's neural respiratory effort and the ventilator's response, affects up to 25% of ventilated breaths and is associated with longer duration of mechanical ventilation and higher mortality. Trigger dyssynchrony encompasses missed triggers (patient effort fails to trigger ventilator delivery), auto-triggering (ventilator delivers a breath without patient effort, often from cardiac oscillations or circuit leak), and double-triggering (two consecutive ventilator breaths delivered for a single neural inspiration, occurring when the set inspiratory time is shorter than the patient's neural inspiratory time). Flow dyssynchrony occurs in volume-controlled ventilation when the patient's inspiratory demand exceeds the set flow rate, producing the characteristic concave or "scooped" pressure-time waveform; solutions include increasing the flow rate, transitioning to a pressure-targeted mode, or reducing sedation if the elevated demand reflects an appropriate respiratory drive. Cycle dyssynchrony refers to premature or delayed termination of the ventilator breath relative to the patient's neural inspiratory time. Detection relies on careful visual inspection of ventilator waveforms, Edi monitoring where available, and automated asynchrony indices provided by some modern ventilators.

<image>A waveform troubleshooting guide for mechanical ventilation showing six common problems. Each panel displays pressure-time and flow-time waveforms with annotations: (1) Normal VCV waveform (reference); (2) Auto-PEEP: expiratory flow does not return to zero before next breath, with end-expiratory hold showing trapped pressure; (3) Flow starvation: concave pressure-time waveform in VCV with patient effort scooping the inspiratory pressure down; (4) Double-triggering: two consecutive triggered breaths without full expiration between them; (5) Missed trigger: visible deflection in pressure/flow waveform without ventilator response; (6) High resistance: elevated Ppeak with normal Pplat, increased Ppeak-Pplat gradient, with slow expiratory flow decay. Label the abnormality and suggested intervention for each panel.</image>

Ventilator Weaning and Liberation

Readiness Assessment

Daily screening for spontaneous breathing trial readiness is a fundamental practice that should be performed on every mechanically ventilated patient. The screening criteria encompass several domains: the underlying cause of respiratory failure should be improving or resolved; the FiO2 should be 0.40 or less and PEEP should be 8 cmH2O or less; adequate oxygenation should be confirmed with SpO2 of 88% or higher on current settings; hemodynamic stability should be present with no or only low-dose vasopressor support; the patient should ideally be awake and able to follow commands; and no procedures requiring deep sedation should be planned. Failure to perform systematic daily screening is a well-documented contributor to prolonged mechanical ventilation.

Spontaneous Breathing Trial (SBT)

The spontaneous breathing trial is the critical test of a patient's readiness for extubation. Current guidelines from the ATS and ACCP (2017) recommend a duration of 30 minutes, as evidence demonstrates that 30-minute trials are as effective as 120-minute trials in predicting extubation success while avoiding unnecessary delays in liberation. The SBT may be conducted via several methods: a T-piece trial (the patient breathes through the endotracheal tube with no ventilator assistance), low-level pressure support of 5 to 8 cmH2O, automatic tube compensation, or CPAP of 5 cmH2O. Failure criteria during the SBT include a respiratory rate exceeding 35 breaths per minute, SpO2 below 88%, a heart rate change exceeding 20% from baseline, systolic blood pressure below 90 or above 180 mmHg, a rapid shallow breathing index (f/VT) exceeding 105, and signs of agitation, distress, or diaphoresis. Successful completion of the SBT should prompt extubation, provided there are no additional risk factors for post-extubation stridor and the patient demonstrates adequate cough strength and secretion management.

Rapid Shallow Breathing Index (RSBI)

The rapid shallow breathing index, calculated as the respiratory rate divided by the tidal volume in liters (f/VT), is the most widely used weaning predictor. An RSBI below 105 is predictive of successful extubation with a sensitivity of approximately 95% but a specificity of only approximately 65%, meaning it is effective at identifying patients likely to succeed but less reliable at identifying those who will fail. An RSBI exceeding 105 predicts SBT or extubation failure but should not be used as the sole determinant for withholding an extubation attempt, as clinical context must always be integrated.

Cuff Leak Test

The cuff leak test assesses the risk of post-extubation stridor from laryngeal edema. The endotracheal tube cuff is deflated, and the presence and volume of an audible leak are assessed. If no audible leak is detected or if the measured leak volume is less than 110 mL (or less than 10% of the tidal volume), the patient is considered at high risk for post-extubation stridor. In high-risk patients, pre-treatment with dexamethasone 4 mg intravenously every 6 hours for four doses, initiated 12 to 24 hours before planned extubation, reduces the incidence of stridor and reintubation. Patients at elevated risk for laryngeal edema include those with prolonged intubation exceeding 7 days, prior failed extubation, and traumatic or difficult intubation.

Post-Extubation Support

The immediate post-extubation period is a vulnerable window during which targeted respiratory support can prevent reintubation. Prophylactic non-invasive ventilation, applied immediately upon extubation, reduces reintubation rates in high-risk patients, defined as those with COPD, hypercapnia during the SBT, congestive heart failure, or advanced age. This intervention should be planned before extubation and applied without delay, as the benefit is in prevention rather than rescue. Prophylactic high-flow nasal cannula reduces reintubation rates in low-risk patients, as demonstrated by Hernandez and colleagues in 2016. The HIGH-WEAN trial demonstrated that alternating high-flow nasal cannula with non-invasive ventilation may be superior to high-flow nasal cannula alone in high-risk post-extubation patients, providing the rationale for a combination approach.

Sedation and Analgesia

Sedation Strategy

Modern sedation management in the ICU follows the PADIS (Pain, Agitation/sedation, Delirium, Immobility, Sleep disruption) guidelines, which advocate an analgesia-first approach in which pain is assessed and treated before sedation is administered. The target sedation depth for most mechanically ventilated patients is light sedation, corresponding to a Richmond Agitation-Sedation Scale (RASS) score of -1 to 0, as deep sedation is associated with longer duration of mechanical ventilation, increased incidence of delirium, and higher mortality. Daily sedation interruption (spontaneous awakening trial, or SAT) paired with a spontaneous breathing trial forms the foundation of the ABC trial protocol, which demonstrated that this coordinated approach reduces ventilator days and one-year mortality. Regarding specific agents, dexmedetomidine is associated with less delirium than benzodiazepines and facilitates earlier extubation. The SPICE III trial did not demonstrate a mortality benefit with dexmedetomidine-based sedation but confirmed its safety profile and favorable effect on delirium incidence.

Delirium Prevention

Delirium affects 60% to 80% of mechanically ventilated patients and is an independent predictor of prolonged ICU stay, cognitive impairment, and mortality. Major modifiable risk factors include benzodiazepine use (continuous infusions of midazolam or lorazepam are strongly discouraged), anticholinergic medications, physical immobility, and sleep disruption. The ABCDEF bundle represents the evidence-based framework for delirium prevention and management: Assess and prevent pain, Both SAT and SBT, Choice of appropriate analgesia and sedation, Delirium monitoring and management (using validated tools such as the CAM-ICU), Early mobility and exercise, and Family engagement. Implementation of the full ABCDEF bundle has been demonstrated to reduce delirium prevalence, shorten ventilator days, and improve survival.

Key Clinical Pearls

• Always use IDEAL body weight (not actual body weight) for tidal volume calculation; using actual body weight in obese patients leads to dangerously large tidal volumes
• Driving pressure (Pplat - PEEP) is the strongest ventilator variable associated with ARDS mortality in observational data; target <= 14 cmH2O
• Auto-PEEP is a hidden cause of hemodynamic instability and ventilator dyssynchrony; always perform end-expiratory hold in patients with obstructive disease or unexplained hemodynamic compromise
• An SBT duration of 30 minutes is sufficient (ATS/ACCP guideline); prolonging to 120 minutes does not improve prediction of extubation success and may unnecessarily delay liberation
• Prophylactic NIV immediately after extubation reduces reintubation rates in high-risk patients (COPD, hypercapnia, elderly, CHF); this should be planned before extubation, not applied after failure

References

1. Fan E, Del Sorbo L, Goligher EC, et al. An Official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine Clinical Practice Guideline: Mechanical Ventilation in Adult Patients with Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2017;195(9):1253-1263.
2. Ouellette DR, Patel S, Girard TD, et al. Liberation From Mechanical Ventilation in Critically Ill Adults: An Official American College of Chest Physicians/American Thoracic Society Clinical Practice Guideline. Chest. 2017;151(1):166-180.
3. Girard TD, Kress JP, Fuchs BD, et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet. 2008;371(9607):126-134.
4. Devlin JW, Skrobik Y, Gelinas C, et al. Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU. Crit Care Med. 2018;46(9):e825-e873. (PADIS)
5. Thille AW, Muller G, Gacouin A, et al. Effect of Postextubation High-Flow Nasal Oxygen With Noninvasive Ventilation vs High-Flow Nasal Oxygen Alone on Reintubation Among Patients at High Risk of Extubation Failure: A Randomized Clinical Trial. JAMA. 2019;322(15):1465-1475. (HIGH-WEAN)

Read this lecture as Markdown